Controlling Glucose during Elective hip Surgery To study the influence on Coagulation.

Recruiting

• Conditions: peri-operative glycemic control; hip surgery; liraglutide

• Registration Number: NL-OMON26959
• Lead Sponsor: Academic Medical Centre Amsterdam

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 36

Inclusion Criteria

1. Signed informed consent;

2. Planned for elective hip replacement surgery;

Exclusion Criteria

1. Known type 1 or type 2 diabetes mellitus;

2. Oral corticosteroid use;

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The difference in mean glucose between the CG and the LG at day 3 after surgery.

Secondary Outcome Measures

Name	Time	Method
The difference in mean glucose between CG and the LG during surgery, the between group difference in mean coagulation parameters, the between group difference in mean glucagon and cortisol levels and the difference in proportion of patients who have glucose values in fasting state below 7.8 mmol/l at day 3 after surgery.